<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="editorial" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">abcimg</journal-id>
<journal-title-group>
<journal-title>ABC Imagem Cardiovascular</journal-title>
<abbrev-journal-title abbrev-type="publisher">Arq Bras Cardiol: Imagem cardiovasc.</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2675-312X</issn>
<publisher>
<publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.36660/abcimg.20240109i</article-id>
<article-id pub-id-type="publisher-id">abcimg.20240109i</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Use of X (Formerly Twitter) in Cardiovascular Imaging: Opportunities and Risks</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="editor">
<contrib-id contrib-id-type="orcid">0000-0001-7046-8707</contrib-id>
<name><surname>Felix</surname><given-names>Alex dos Santos</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c1"/>
</contrib>
<aff id="aff1">
<label>1</label>
<institution content-type="orgname">National Institute of Cardiology</institution>
<addr-line>
<named-content content-type="city">Rio de Janeiro</named-content>
<named-content content-type="state">RJ</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">National Institute of Cardiology, Rio de Janeiro, RJ – Brazil</institution>
</aff>
</contrib-group>
<author-notes>
<corresp id="c1"><label>Mailing Address:</label> <bold>Alex dos Santos Felix</bold> • National Institute of Cardiology. Rua das Laranjeiras, 374. Postal code: <postal-code>20521-290</postal-code>. Rio de Janeiro, RJ – Brazil E-mail: <email>alexsfelix@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub">
<day>09</day>
<month>12</month>
<year>2024</year></pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2024</year>
</pub-date>
<volume>37</volume>
<issue>4</issue>
<elocation-id>e20240109</elocation-id>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
</license>
</permissions>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Cardiac Imaging Techniques</kwd>
<kwd>Echocardiography</kwd>
<kwd>Social Media</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="10"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Social media has decisively transformed the way we disseminate medical information and knowledge, launching new digital tools to boost scientific debate and help redesign healthcare education. Globally, X, formerly Twitter, stands out in the medical field as a more scientific platform, with great interaction between peers, helping doctors and other healthcare professionals from all continents connect to discuss publications, debate scientific evidence, and share clinical experiences. X is also highly important as a channel for the dissemination of scientific events, courses and conferences. In a recent study involving healthcare professionals from 35 countries, Guerra et al. identified that X was the second most accessed social network (55.1%), second only to LinkedIn (60.8%).<sup><xref ref-type="bibr" rid="B1">1</xref></sup> The speed of dissemination of information and interactivity are strong points of X, with the possibility of bringing together younger doctors, or those who work in institutions with lower complexity, with renowned professionals who work in large centers around the world. This valuable exchange of experiences creates a large virtual &quot;grand round,&quot; bringing other professionals into the debate and allowing for the discussion of controversial technical concepts and challenging clinical cases.</p>
<p>X was founded in 2006, still as Twitter, as an environment for the exchange of short messages, initially limited to 140 characters, having been extended to 280 characters in 2017, and recently relaxed to 25,000 characters for Premium users only. According to the Digital Report 2024, Brazil is the second country in the world where users spend the most time online.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> There are 245 million users on X, with more than 500 million posts per day, making Brazil the fourth largest user base of this platform in the world.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
<sec>
<title>Current use of X in cardiovascular imaging</title>
<p>In the area of cardiovascular imaging, despite the frequent focus on multimodality in publications, which greatly reflect our clinical practice, in X there is a subdivision of content among the main diagnostic modalities, identified by the abbreviations after the symbol &quot;#&quot; (&quot;hashtag&quot;): 1 - #EchoFirst: echocardiography, 2 - #YesCCT: cardiac computed tomography, 3 - #WhyCMR: cardiac magnetic resonance and 4 - #CVNuc nuclear cardiology (<xref ref-type="table" rid="t1">Table 1</xref>). The use of these &quot;hashtags&quot; enables a targeted search by field of research within the platform itself, facilitating the screening of content related to each of these specific areas. Using the search tool, one can also select posts specifically by pathologies, using the # followed by the term (example: #Ebstein), or search by name for specific renowned physicians in certain areas of expertise. It is possible to monitor the traffic of publications marked with # (metadata tags) using specific programs or websites for this purpose (<ext-link ext-link-type="uri" xlink:href="https://www.symplur.com">https://www.symplur.com</ext-link>, for example). During conferences, specific &quot;hashtags&quot; are usually created to mark content published in correlation with the activities and schedule of these events, which can be used by congress participants in general or by teams focused on this dissemination, the so-called social media teams (#SoMe), or even social media &quot;ambassadors&quot; (&quot;#SoMe ambassadors&quot;). As an example, during the American Society of Echocardiography Congress in June 2024, using the #ASE2024 tag in the posts, we can see that in the period from 06/11 to 06/16, 2024, there were 2,019 related posts, with an incredible 24,292,000 impressions (<xref ref-type="fig" rid="f1">Figure 1</xref>), data that allows us to measure the reach and penetration of the event on this platform, like a &quot;thermometer&quot; that helps to evaluate the performance of specific activities and the impact of the event in general, as well as plan future actions.</p>
<table-wrap id="t1">
<label>Table 1</label>
<caption>
<title>Top hashtags (#) related to cardiovascular imaging identified in X</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="50%">
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#C58874">
<th align="left" valign="middle">Acronym</th>
<th align="center" valign="middle">Significado</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr>
<td align="left" valign="middle">#EchoFirst</td>
<td align="center" valign="middle">Echocardiography</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#YesCCT</td>
<td align="center" valign="middle">Cardiac computed tomography</td>
</tr>
<tr>
<td align="left" valign="middle">#WhyCMR</td>
<td align="center" valign="middle">Cardiac magnetic resonance</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#CVNuc</td>
<td align="center" valign="middle">Nuclear cardiology</td>
</tr>
<tr>
<td align="left" valign="middle">#TreatTR</td>
<td align="center" valign="middle">Interventional treatment of tricuspid regurgitation</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#3DEcho</td>
<td align="center" valign="middle">3D echocardiography</td>
</tr>
<tr>
<td align="left" valign="middle">#IC</td>
<td align="center" valign="middle">Interventional Cardiology</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#CardioTwitter</td>
<td align="center" valign="middle">Cardiology community</td>
</tr>
<tr>
<td align="left" valign="middle">#CardioED</td>
<td align="center" valign="middle">Education in cardiology</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#CVImaging</td>
<td align="center" valign="middle">Cardiovascular Imaging</td>
</tr>
<tr>
<td align="left" valign="middle">#VHD</td>
<td align="center" valign="middle">Valvular heart disease</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#ACHD</td>
<td align="center" valign="middle">Adult congenital heart disease</td>
</tr>
<tr>
<td align="left" valign="middle">#HF</td>
<td align="center" valign="middle">Heart failure</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f1">
<label>Figure 1</label>
<caption>
<title>Analysis of posts related to the hashtag #ASE2024 during the American Society of Echocardiography congress 2024, illustrating reach and impact of these posts and the participation of Top digital influencers during the period from 11-16 june 2024 . Data Source: Symplur (TM) platform.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240109-gf01.tif"/>
</fig>
<p>In clinical practice, we often come across rare and challenging diseases, in which experience can be decisive for a quick and effective diagnosis, and discussion among peers is essential for this task. Diseases with regional distribution may be rare in some countries and endemic in other parts of the world, such as rheumatic heart disease, which is endemic in South and Central America. Echocardiographic images can be disseminated quickly, for example, and make it easier for a doctor with great expertise on the matter to help another who has never seen the disease to make the correct diagnosis and guide possible therapeutic options, simulating a virtual &quot;Heart Team&quot; in real time.</p>
<p>With the use of X, we can also disseminate the best use of new techniques and tools in cardiovascular imaging, for example, in the form of tutorials (&quot;tweetorials&quot;)<sup><xref ref-type="bibr" rid="B3">3</xref></sup> or by illustrating their use in the context of specific diseases and commented cases. Due to character limitations, many tutorials are designed to develop a subject sequentially, with linked posts on a given topic, called &quot;threads&quot;, which can be illustrated with figures or videos, providing more consistent information on a given subject. To this content, we can also add interactive surveys on the subject, called &quot;polls&quot;, which enhance engagement and generate anonymous data that helps identify patterns and trends, and can even be used in scientific publications, conference presentations, or related posts.</p>
</sec>
<sec>
<title>In summary, below are the main uses of the X platform in cardiovascular imaging:</title>
<list list-type="roman-upper">
<list-item><p>Dissemination of specific diagnostic techniques or approaches, through discussions or illustrative videos. For example, the description of new echocardiographic windows (<ext-link ext-link-type="uri" xlink:href="https://x.com/alexsfelixecho/status/1813967278964101463">https://x.com/alexsfelixecho/status/1813967278964101463</ext-link>) or the popularization of other less used echocardiographic windows, such as the right parasternal (<ext-link ext-link-type="uri" xlink:href="https://x.com/nat_echo/status/1508827908101529601">https://x.com/nat_echo/status/1508827908101529601</ext-link>). Younger doctors in training, such as residents or fellows, in particular, use social media to seek tips and ask questions to more experienced doctors;</p></list-item>
<list-item><p>Use for recruitment of research centers or even inclusion of patients in randomized scientific studies;</p></list-item>
<list-item><p>Journal clubs and other forms of interaction between professionals through X for academic and scientific purposes. Discussions of important topics or recent publications with an analysis of their impact on clinical practice are often sponsored by major cardiovascular imaging journals or initiatives by societies, such as the ASE Journal Club of the American Society of Echocardiography. All of these activities have specific hashtags that mark the discussions;</p></list-item>
<list-item><p>Discussion of complex cases, including images and videos of challenging cases, which elicit opinions from experts on the subject, and discussions of possible diagnostic complements and therapeutic approaches;</p></list-item>
<list-item><p>Tutorials, also called &quot;tweetorials&quot;, sequential posts on a subject that can cover diverse topics from basic concepts, statistical data from related publications, and references to new research and innovations, with the intention of an abbreviated review of a given topic or discussion on a specific article or trial;</p></list-item>
<list-item><p>Publications aimed at patients and the lay population, with content focused on generating knowledge about certain diseases (&quot;awareness&quot;), their diagnosis, and possible treatments;<sup><xref ref-type="bibr" rid="B4">4</xref></sup></p></list-item>
<list-item><p>Use to enable the community to follow the latest news on trials or publications, released at major conferences, in real time, with the possibility of discussion and focus on important points about new guidelines and their impact on our clinical practice;</p></list-item>
<list-item><p>Encouragement of inclusion or visibility of a specific group, such as greater female inclusion in cardiology, like the #WIC (&quot;women in cardiology&quot;) movement,<sup><xref ref-type="bibr" rid="B5">5</xref></sup> reducing the difference in academic and scientific representation and participation;</p></list-item>
<list-item><p>Forum for critical discussions of articles, open in a democratic manner for public debate among professionals in the field.</p></list-item>
</list>
<p>When used properly, X opens doors to knowledge and is an important source of updates and case discussions. Some accounts are particularly active and useful, posting relevant content and sparking important discussions for education in the area of cardiovascular imaging. It would be impossible to include the accounts of all relevant digital influencers in the area of cardiovascular imaging on X in this publication, but <xref ref-type="table" rid="t2">Table 2</xref> suggests 51 accounts to follow, which can serve as a good start for new X users.</p>
<table-wrap id="t2">
<label>Table 2</label>
<caption>
<title>Some profiles of professionals related to cardiovascular imaging recommended by the author.</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="33%">
<col/>
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#C58874">
<th align="left" valign="middle">Profile (@)</th>
<th align="center" valign="middle">Profissional</th>
<th align="center" valign="middle">Country</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@alcantaramonica</td>
<td align="center" valign="middle">Monica Alcantara</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@alex1708ander</td>
<td align="center" valign="middle">Alexander Mladenow</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@alexsfelixecho</td>
<td align="center" valign="middle">Alex Felix</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@AntonioBarros_</td>
<td align="center" valign="middle">Antonio Carlos L. de Barros Filho</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@argulian</td>
<td align="center" valign="middle">Edgar Argulian</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@cardiopedhnn</td>
<td align="center" valign="middle">Jorge Faerron</td>
<td align="center" valign="middle">COSTA RICA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@CASivaram1</td>
<td align="center" valign="middle">Chittur Sivaram</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@ctinocomesquita</td>
<td align="center" valign="middle">Claudio Tinoco Mesquita</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@denisamuraru</td>
<td align="center" valign="middle">Denisa Muraru</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr>
<td align="left" valign="middle">@DonalErwan</td>
<td align="center" valign="middle">Erwan Donal</td>
<td align="center" valign="middle">FRANCE</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@dr_benoy_n_shah</td>
<td align="center" valign="middle">Benoy Shah</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr>
<td align="left" valign="middle">@drahmedmohsen85</td>
<td align="center" valign="middle">Ahmed Mohsen</td>
<td align="center" valign="middle">EGYPT</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@drEdgarFuentes</td>
<td align="center" valign="middle">Edgar Fuentes Molina</td>
<td align="center" valign="middle">COSTA RICA</td>
</tr>
<tr>
<td align="left" valign="middle">@drozgeozden</td>
<td align="center" valign="middle">Ozge Ozden Kayhan</td>
<td align="center" valign="middle">TURKEY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@DrRajeshG1</td>
<td align="center" valign="middle">Gopalan Nair Rajesh</td>
<td align="center" valign="middle">INDIA</td>
</tr>
<tr>
<td align="left" valign="middle">@echo_stepbystep</td>
<td align="center" valign="middle">Vladyslav Kavalerchyk</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@EchoSoliman</td>
<td align="center" valign="middle">Hatem Soliman</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr>
<td align="left" valign="middle">@echotalk</td>
<td align="center" valign="middle">Jose Roberto R. Matos-Souza</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@ecocardio_cl</td>
<td align="center" valign="middle">Julián Vega Auday</td>
<td align="center" valign="middle">CHILE</td>
</tr>
<tr>
<td align="left" valign="middle">@EGarciaSayan</td>
<td align="center" valign="middle">Enrique Garcia-Sayan</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@FGraziani_Grace</td>
<td align="center" valign="middle">Francesca Graziani</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr>
<td align="left" valign="middle">@fiore_corrado</td>
<td align="center" valign="middle">Corrado Fiore</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@GE_IanMc</td>
<td align="center" valign="middle">Ian McLeod</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr>
<td align="left" valign="middle">@GoncalvesCortez</td>
<td align="center" valign="middle">Arthur Cortez</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@HeartToProve</td>
<td align="center" valign="middle">Carlos El-Tallawi</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@iamritu</td>
<td align="center" valign="middle">Ritu Thamman</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@Irina67790690</td>
<td align="center" valign="middle">Irina Akhmedova</td>
<td align="center" valign="middle">KYRGYZSTAN</td>
</tr>
<tr>
<td align="left" valign="middle">@KemalogluOz</td>
<td align="center" valign="middle">Tugba Kemaloglu Oz</td>
<td align="center" valign="middle">AUSTRALIA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@kevin_domingues</td>
<td align="center" valign="middle">Kevin Domingues</td>
<td align="center" valign="middle">PORTUGAL</td>
</tr>
<tr>
<td align="left" valign="middle">@LopezOpitz</td>
<td align="center" valign="middle">J. Lopez-Opitz</td>
<td align="center" valign="middle">CHILE</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@lpbadano</td>
<td align="center" valign="middle">Luigi P. Badano</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr>
<td align="left" valign="middle">@MAecocardio</td>
<td align="center" valign="middle">Miguel A. Garcia Fernandez</td>
<td align="center" valign="middle">SPAIN</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@marcelohaertel</td>
<td align="center" valign="middle">Marcelo Haertel Miglioranza</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@marciomp50</td>
<td align="center" valign="middle">Marcio Mendes</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@NadeenFaza</td>
<td align="center" valign="middle">Nadeen N. Faza</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@NMerke</td>
<td align="center" valign="middle">Nicolas Merke</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@ono_cardiology</td>
<td align="center" valign="middle">Juan Lopez-Mattei</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@OungSavly</td>
<td align="center" valign="middle">Oung Savly</td>
<td align="center" valign="middle">CAMBODIA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@papadocardio</td>
<td align="center" valign="middle">Konstantinos Papadopoulos</td>
<td align="center" valign="middle">GREECE</td>
</tr>
<tr>
<td align="left" valign="middle">@pattypellikka</td>
<td align="center" valign="middle">Patricia Pellikka</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@purviparwani</td>
<td align="center" valign="middle">Purvi Parwani</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@RodrigogpLima</td>
<td align="center" valign="middle">Rodrigo G. P. Lima</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@RODRIGOVISCONT1</td>
<td align="center" valign="middle">Rodrigo Visconti</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@Sarah_Moharem</td>
<td align="center" valign="middle">Sarah Moharem Elgamal</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@senguptasp</td>
<td align="center" valign="middle">Shantanu Sengupta</td>
<td align="center" valign="middle">INDIA</td>
</tr>
<tr>
<td align="left" valign="middle">@StellEkaterina</td>
<td align="center" valign="middle">Ekaterina Stellbrink</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@strain_rate</td>
<td align="center" valign="middle">Asbjørn Støylen</td>
<td align="center" valign="middle">NORWAY</td>
</tr>
<tr>
<td align="left" valign="middle">@VazyurVasquez</td>
<td align="center" valign="middle">Zuilma Vásquez</td>
<td align="center" valign="middle">MEXICO</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@VDelgadoGarcia</td>
<td align="center" valign="middle">Victoria Delgado</td>
<td align="center" valign="middle">SPAIN</td>
</tr>
<tr>
<td align="left" valign="middle">@VerwerftJan</td>
<td align="center" valign="middle">Jan Verwerft</td>
<td align="center" valign="middle">BELGIUM</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@VLSorrelImages</td>
<td align="center" valign="middle">V. L. Sorrell</td>
<td align="center" valign="middle">USA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Risks of social media for use in medicine</title>
<p>As with any social media, despite the great advances and functionalities presented, we must observe ethical issues and good conduct in the posts made on X, reinforcing our primary focus on caring for our patients. The platforms are public, and we must remember that patients and their families have access to the posts, and their privacy must be protected (<xref ref-type="table" rid="t3">Table 3</xref>).</p>
<table-wrap id="t3">
<label>Table 3</label>
<caption>
<title>Suggestions on how to make relevant posts on X, avoiding risks and exposure of patients and institutions.</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="33%">
<col/>
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#C58874">
<th align="left" valign="middle">Recommended</th>
<th align="center" valign="middle">Caution</th>
<th align="center" valign="middle">What not to do</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">Follow your institution&apos;s and country&apos;s policies.</td>
<td align="center" valign="middle">When addressing sensitive topics (religion, politics).</td>
<td align="center" valign="middle">Never share patient data.</td>
</tr>
<tr>
<td align="left" valign="middle">Pursue a specific niche/area of interest.</td>
<td align="center" valign="middle">Always consider how a meme or figure can be interpreted.</td>
<td align="center" valign="middle">Never share photos of patients.</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">Try to post in accordance with best practices/common sense.</td>
<td align="center" valign="middle">When posting clinical cases and images, be careful not to personalize and expose patients.</td>
<td align="center" valign="middle">Do not share institutional data, dates, or anything that could indirectly lead to patient identification.</td>
</tr>
<tr>
<td align="left" valign="middle">Try to answer technical questions about your post.</td>
<td align="center" valign="middle">Consider separating professional and personal profiles.</td>
<td align="center" valign="middle">Do not give specific medical advice that could be construed as diagnostic or treatment definitions.</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">Always give credit when retweeting something.</td>
<td align="center" valign="middle">Always make it clear if there is any conflict of interest with the post.</td>
<td align="center" valign="middle">Do not discuss medical issues directly with patients on X.</td>
</tr>
<tr>
<td align="left" valign="middle">Be professional and courteous in your posts.</td>
<td align="center" valign="middle">Try to control the amount of time spent on social media.</td>
<td align="left" valign="middle"/>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">Follow opinion -makers in your field.</td>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>There are some risks to using social media to post medical content:</title>
<list list-type="roman-upper">
<list-item><p>Patient privacy is the main issue; we should never expose their data nor any form of identification;</p></list-item>
<list-item><p>We should never expose other professionals or institutions through posts containing personal opinions, or that expose data on treatments or patients admitted to these institutions;</p></list-item>
<list-item><p>Limiting the number of characters or even the format of the publication of posts can lead to inadequate communication, leading to erroneous interpretations. Written communication, in itself, can often be inadequate, due to the lack of tone or context, and can lead to erroneous conclusions in some cases;</p></list-item>
<list-item><p>The lack of peer review of data or information, can allow information with no scientific basis to be presented as correct and definitive;</p></list-item>
<list-item><p>There is no regulation of activities or checking whether people are really doctors or specialists in a given area, which affects the credibility of the posts.</p></list-item>
</list>
</sec>
<sec>
<title>Best practices in using X for cardiovascular imaging</title>
<p>Based on that presented above, good practices for the use of social media in the area of cardiovascular imaging are necessary, in such a way that we can maintain the ethical and professional care of our patients<sup><xref ref-type="bibr" rid="B6">6</xref></sup> and continue to pursue the goal of promoting quality and learning, with the use of this important communication and information dissemination tool.</p>
<p>The acronym RESPECT summarizes many of these considerations (<xref ref-type="fig" rid="f2">Figure 2</xref>), guiding posts with (R)esponsibility, (E)vidence supporting the statements, (S)ensitivity and common sense in the content and form with which we put together the posts, preserving the (P)rivacy of patients, for (E)ducational or research purposes, obtaining the (C)onsent of the patient when applicable, and always using (T)echnically-based information.</p>
<fig id="f2">
<label>Figure 2</label>
<caption>
<title>Acronym for good conduct standards when publishing technical posts in the area of cardiovascular imaging on X: RESPECT. Main hashtags that identify the main methods of cardiovascular imaging: #EchoFirst: echocardiography, #YesCCT: cardiac computed tomography, #WhyCMR: cardiac magnetic resonance and #CVNuc nuclear cardiology.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240109-gf02.tif"/>
</fig>
<p>Institutional rules for the display of images and information must also be observed, in addition to always making any conflicts of interest transparent when the professional has a relationship with the industry, medical journals, a society or a specific trial, when the posts are related to these.</p>
<p>Regarding opinions and comments posted on the platform, it is always important to remember that medicine requires human contact, the doctor-patient relationship, and a thorough physical examination. Therefore the analysis of selected images or fragmented information, and not inserted into a &quot;whole&quot; that includes all of these factors, can lead to errors in diagnosis and conduct, and must therefore be used with common sense and caution. Many doctors place the phrase &quot;retweet ≠ endorsement&quot;, &quot;personal views ≠ medical advice&quot;, &quot;tweets = my opinion&quot; in their profile as a way of making it clear that comments posted there reflect only their personal opinions and cannot serve as a definition of conduct.</p>
</sec>
<sec>
<title>Academic use of X</title>
<p>The use of social media has changed the way academia determines influence in the medical field and its power over the content of information. Today, anyone can freely publish whatever they want in real time, with no restrictions or peer-review processes, meaning that belonging to academia is no longer a prerequisite for influence and recognition. New initiatives have emerged from the digital connections and networking that are established through social media, such as the creation of discussion groups, digital communities, or even the emergence of initiatives that bring together people who only know each other digitally and who decide to organize projects together, such as virtual or in-person meetings, the collaborative writing of articles, the writing of books, among others. As an example, recently, in 2022, a cardiology society was created in a fully digital and online environment, the GSOC (Global Society of Cardiology - account X: @GSoCers), bringing together members from several countries, all collaborating virtually. On the initiative of this group, the first Cardiology Congress in Metaverse was held, which was attended by renowned speakers in a completely virtual environment, with a large audience (<xref ref-type="fig" rid="f3">Figure 3</xref>).</p>
<fig id="f3">
<label>Figure 3</label>
<caption>
<title>Example of digital networking on X, giving rise to scientific, educational and networking initiatives, like in the field of Cardiovascular Imaging. These images are from an entirely virtual conference held in the Metaverse (sponsored by GSOC) with avatars representing speakers and audience.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240109-gf03.tif"/>
</fig>
<p>X can also be used as a research tool, through surveys or polls, in which data can be collected directly through user participation. Another way to promote research is through the direct recruitment of eligible individuals for inclusion in registries, through direct calls on social networks that can target patients themselves, other professionals, or institutions that may have patients who would benefit from such participation.</p>
</sec>
<sec>
<title>Despite being a social network, some rules of good conduct are important for operating on X:</title>
<list list-type="roman-upper">
<list-item><p>It is important to cite references or tag experts, authors, or editors when discussing an article, or when posting any part of it or a figure/table.</p></list-item>
<list-item><p>You should always give due credit to the authorship of another user&apos;s post when reposting it or when making a new personal post using material from it, whether in part or in full, be it a text, an image, or a video.</p></list-item>
<list-item><p>It is important to always use professional discourse when discussing scientific matters, with a respectful tone, always in the most technical manner possible.</p></list-item>
<list-item><p>It should always be made clear in the post when the use of a technique is &quot;off-label&quot;.</p></list-item>
</list>
<p>Studies show that articles published on social media gain greater visibility and number of accesses, citations, and downloads,<sup><xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref></sup> encouraging X users to search for content on the digital platforms of these online journals.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> X is an important tool for promoting case reports or scientific research,<sup><xref ref-type="bibr" rid="B10">10</xref></sup> and access to scientific papers from social media is monitored by alternative metrics, such as the Altmetric index (<ext-link ext-link-type="uri" xlink:href="https://www.altmetric.com">https://www.altmetric.com</ext-link>), which includes references to research beyond medical publications, including: citations in the press and websites, online blogs, Wikipedia, and social networks, such as X. The Altmetric index is linked to the article&apos;s URL address and can assess an article&apos;s performance in terms of impressions and reach among readers more quickly than conventional indexes (H-Index).</p>
</sec>
</sec>
<sec sec-type="conclusions">
<title>Conclusion</title>
<p>The use of social media in the field of cardiovascular imaging has revolutionized the way we connect and share knowledge. X has features that make it an attractive platform for discussing clinical cases, disseminating new technologies and scientific research in real time, in a dynamic and interactive way. We must always seek to observe the rules of good practice, adhering to ethical limits and protecting the privacy of patients, remembering that X is another important tool for the benefit of our patients, who are the focus of care.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Guerra</surname><given-names>F</given-names></name>
<name><surname>Linz</surname><given-names>D</given-names></name>
<name><surname>Garcia</surname><given-names>R</given-names></name>
<name><surname>Kommata</surname><given-names>V</given-names></name>
<name><surname>Kosiuk</surname><given-names>J</given-names></name>
<name><surname>Chun</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>The Use of Social Media for Professional Purposes by Healthcare Professionals: The #intEHRAct Survey</article-title>
<source>Europace</source>
<year>2022</year>
<volume>24</volume>
<issue>4</issue>
<fpage>691</fpage>
<lpage>696</lpage>
<pub-id pub-id-type="doi">10.1093/europace/euab244</pub-id>
</element-citation>
<mixed-citation>Guerra F, Linz D, Garcia R, Kommata V, Kosiuk J, Chun J, et al. The Use of Social Media for Professional Purposes by Healthcare Professionals: The #intEHRAct Survey. Europace. 2022;24(4):691-696. doi: 10.1093/europace/euab244.</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>DataReportal</collab>
</person-group>
<source>Digital 2024 Report [Internet]</source>
<publisher-loc>Stanley St</publisher-loc>
<publisher-name>Kepios</publisher-name>
<year>2024</year>
<date-in-citation content-type="access-date">[cited 2024 Nov 11]</date-in-citation>
<comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://datareportal.com/reports/digital-2024-global-overview-report">https://datareportal.com/reports/digital-2024-global-overview-report</ext-link></comment>
</element-citation>
<mixed-citation>DataReportal. Digital 2024 Report [Internet]. Stanley St: Kepios; 2024 [cited 2024 Nov 11]. Available from: https://datareportal.com/reports/digital-2024-global-overview-report.</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Alasnag</surname><given-names>M</given-names></name>
<name><surname>Mamas</surname><given-names>M</given-names></name>
<name><surname>Fischman</surname><given-names>D</given-names></name>
<name><surname>Brugaletta</surname><given-names>S</given-names></name>
<name><surname>Safirstein</surname><given-names>J</given-names></name>
<name><surname>Meier</surname><given-names>P</given-names></name>
<etal/>
</person-group>
<article-title>View Point on Social Media Use in Interventional Cardiology</article-title>
<source>Open Heart</source>
<year>2019</year>
<volume>6</volume>
<issue>1</issue>
<elocation-id>e001031</elocation-id>
<pub-id pub-id-type="doi">10.1136/openhrt-2019-001031</pub-id>
</element-citation>
<mixed-citation>Alasnag M, Mamas M, Fischman D, Brugaletta S, Safirstein J, Meier P, et al. View Point on Social Media Use in Interventional Cardiology. Open Heart. 2019;6(1):e001031. doi: 10.1136/openhrt-2019-001031.</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Chirumamilla</surname><given-names>S</given-names></name>
<name><surname>Gulati</surname><given-names>M</given-names></name>
</person-group>
<article-title>Patient Education and Engagement through Social Media</article-title>
<source>Curr Cardiol Rev</source>
<year>2021</year>
<volume>17</volume>
<issue>2</issue>
<fpage>137</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.2174/1573403X15666191120115107</pub-id>
</element-citation>
<mixed-citation>Chirumamilla S, Gulati M. Patient Education and Engagement through Social Media. Curr Cardiol Rev. 2021;17(2):137-43. doi: 10.2174/1573403X15666191120115107.</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Beygui</surname><given-names>N</given-names></name>
<name><surname>Bahl</surname><given-names>D</given-names></name>
<name><surname>Mansour</surname><given-names>C</given-names></name>
<name><surname>Michos</surname><given-names>ED</given-names></name>
<name><surname>Velagapudi</surname><given-names>P</given-names></name>
<name><surname>Grapsa</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>Social Media as a Tool to Advance Women in Cardiology: Paving the Way for Gender Equality and Diversity</article-title>
<source>CJC Open</source>
<year>2021</year>
<volume>3</volume>
<supplement>12 Suppl</supplement>
<fpage>130</fpage>
<lpage>136</lpage>
<pub-id pub-id-type="doi">10.1016/j.cjco.2021.08.009</pub-id>
</element-citation>
<mixed-citation>Beygui N, Bahl D, Mansour C, Michos ED, Velagapudi P, Grapsa J, et al. Social Media as a Tool to Advance Women in Cardiology: Paving the Way for Gender Equality and Diversity. CJC Open. 2021;3(12 Suppl):130-6. doi: 10.1016/j.cjco.2021.08.009.</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Covas</surname><given-names>P</given-names></name>
<name><surname>Ismail</surname><given-names>H</given-names></name>
<name><surname>Krepp</surname><given-names>J</given-names></name>
<name><surname>Choi</surname><given-names>BG</given-names></name>
<name><surname>Lewis</surname><given-names>JF</given-names></name>
<name><surname>Katz</surname><given-names>RJ</given-names></name>
<etal/>
</person-group>
<article-title>Contemporary Cardiovascular Imaging Advancements and Social Media</article-title>
<source>Curr Treat Options Cardiovasc Med</source>
<year>2021</year>
<volume>23</volume>
<issue>4</issue>
<fpage>25</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1007/s11936-021-00902-9</pub-id>
</element-citation>
<mixed-citation>Covas P, Ismail H, Krepp J, Choi BG, Lewis JF, Katz RJ, et al. Contemporary Cardiovascular Imaging Advancements and Social Media. Curr Treat Options Cardiovasc Med. 2021;23(4):25. doi: 10.1007/s11936-021-00902-9.</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ladeiras-Lopes</surname><given-names>R</given-names></name>
<name><surname>Clarke</surname><given-names>S</given-names></name>
<name><surname>Vidal-Perez</surname><given-names>R</given-names></name>
<name><surname>Alexander</surname><given-names>M</given-names></name>
<name><surname>Lüscher</surname><given-names>TF</given-names></name>
</person-group>
<article-title>Twitter Promotion Predicts Citation Rates of Cardiovascular Articles: A Preliminary Analysis from the ESC Journals Randomized Study</article-title>
<source>Eur Heart J</source>
<year>2020</year>
<volume>41</volume>
<issue>34</issue>
<fpage>3222</fpage>
<lpage>3225</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehaa211</pub-id>
</element-citation>
<mixed-citation>Ladeiras-Lopes R, Clarke S, Vidal-Perez R, Alexander M, Lüscher TF. Twitter Promotion Predicts Citation Rates of Cardiovascular Articles: A Preliminary Analysis from the ESC Journals Randomized Study. Eur Heart J. 2020;41(34):3222-5. doi: 10.1093/eurheartj/ehaa211.</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Parwani</surname><given-names>P</given-names></name>
<name><surname>Martin</surname><given-names>GP</given-names></name>
<name><surname>Mohamed</surname><given-names>MO</given-names></name>
<name><surname>Hajeer</surname><given-names>A</given-names></name>
<name><surname>Nwaokoro</surname><given-names>M</given-names></name>
<name><surname>Narang</surname><given-names>A</given-names></name>
<etal/>
</person-group>
<article-title>Relationship of Altmetric Attention Score to Overall Citations and Downloads for Papers Published in JACC</article-title>
<source>J Am Coll Cardiol</source>
<year>2020</year>
<volume>76</volume>
<issue>6</issue>
<fpage>757</fpage>
<lpage>759</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2020.06.025</pub-id>
</element-citation>
<mixed-citation>Parwani P, Martin GP, Mohamed MO, Hajeer A, Nwaokoro M, Narang A, et al. Relationship of Altmetric Attention Score to Overall Citations and Downloads for Papers Published in JACC. J Am Coll Cardiol. 2020;76(6):757-9. doi: 10.1016/j.jacc.2020.06.025.</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Brown</surname><given-names>SA</given-names></name>
<name><surname>Campbell</surname><given-names>C</given-names></name>
<name><surname>Fradley</surname><given-names>M</given-names></name>
<name><surname>Volgman</surname><given-names>AS</given-names></name>
</person-group>
<article-title>Social Media for Cardiovascular Journals: State of the Art Review</article-title>
<source>Am Heart J Plus</source>
<year>2021</year>
<volume>8</volume>
<fpage>100041</fpage>
<lpage>100041</lpage>
<pub-id pub-id-type="doi">10.1016/j.ahjo.2021.100041</pub-id>
</element-citation>
<mixed-citation>Brown SA, Campbell C, Fradley M, Volgman AS. Social Media for Cardiovascular Journals: State of the Art Review. Am Heart J Plus. 2021;8:100041. doi: 10.1016/j.ahjo.2021.100041.</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>AD</given-names></name>
<name><surname>Feuchtner</surname><given-names>GM</given-names></name>
<name><surname>Weir-McCall</surname><given-names>J</given-names></name>
<name><surname>Shaw</surname><given-names>LJ</given-names></name>
<name><surname>Min</surname><given-names>JK</given-names></name>
<name><surname>Villines</surname><given-names>TC</given-names></name>
</person-group>
<article-title>Accelerating the Future of Cardiac CT: Social Media as sine qua non?</article-title>
<source>J Cardiovasc Comput Tomogr</source>
<year>2020</year>
<volume>14</volume>
<issue>5</issue>
<fpage>382</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcct.2020.01.011</pub-id>
</element-citation>
<mixed-citation>Choi AD, Feuchtner GM, Weir-McCall J, Shaw LJ, Min JK, Villines TC. Accelerating the Future of Cardiac CT: Social Media as sine qua non? J Cardiovasc Comput Tomogr. 2020;14(5):382-85. doi: 10.1016/j.jcct.2020.01.011.</mixed-citation>
</ref>
</ref-list>
</back>
<sub-article article-type="translation" id="S1" xml:lang="pt">
<front-stub>
<article-id pub-id-type="doi">10.36660/abcimg.20240109</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>O Uso do X (Ex-Twitter) na Área de Imagem Cardiovascular: Oportunidades e Riscos</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="editor">
<contrib-id contrib-id-type="orcid">0000-0001-7046-8707</contrib-id>
<name><surname>Felix</surname><given-names>Alex dos Santos</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c2"/>
</contrib>
<aff id="aff2">
<label>1</label>
<addr-line>
<named-content content-type="city">Rio de Janeiro</named-content>
<named-content content-type="state">RJ</named-content>
</addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">National Institute of Cardiology, Rio de Janeiro, RJ – Brasil</institution>
</aff>
</contrib-group>
<author-notes>
<corresp id="c2"><label>Correspondência:</label> <bold>Alex dos Santos Felix</bold> • National Institute of Cardiology. Rua das Laranjeiras, 374. CEP: <postal-code>20521-290</postal-code>. Rio de Janeiro, RJ – Brasil E-mail: <email>alexsfelix@gmail.com</email></corresp>
</author-notes>
<kwd-group xml:lang="pt">
<title>Palavras-chave</title>
<kwd>Técnicas de Imagem Cardíaca</kwd>
<kwd>Ecocardiografia</kwd>
<kwd>Mídias sociais</kwd>
</kwd-group>
</front-stub>
<body>
<sec sec-type="intro">
<title>Introdução</title>
<p>As mídias sociais transformaram de forma decisiva a maneira como difundimos informações e conhecimento médico, trazendo novas ferramentas digitais para impulsionar o debate científico e ajudar a redesenhar os meios de educação na área de saúde. De uma forma global, o X, ou antigo Twitter, se destaca na área médica como uma plataforma que propicia intenso debate técnico, com grande interação entre pares, permitindo que médicos e outros profissionais de saúde de todos os continentes se conectem para discutir publicações, evidências científicas e dividir experiências clínicas. O X também tem grande importância como um canal para a divulgação de eventos científicos, cursos e congressos. Em estudo recente envolvendo profissionais de saúde de 35 países, Guerra e colaboradores identificaram que o X era a segunda rede social mais acessada (55,1%), ficando apenas atrás do LinkedIn (60,8%).<sup><xref ref-type="bibr" rid="B1">1</xref></sup> A rapidez na difusão de informações e a interatividade são pontos altos do X, com a possibilidade de aproximar médicos mais jovens, ou que trabalham em instituições de menor complexidade, de profissionais renomados que atuam em grandes centros ao redor do mundo. Essa valiosa troca de experiências constrói um grande &quot;round&quot; virtual, agregando outros profissionais ao debate, permitindo a discussão de conceitos técnicos controversos e casos clínicos desafiadores.</p>
<p>O X foi fundado em 2006, ainda como Twitter, como um ambiente de troca de mensagens curtas, inicialmente limitadas a 140 caracteres, tendo sido estendido para 280 caracteres em 2017, e flexibilizado recentemente para 25.000 caracteres apenas para usuários Premium. Segundo o Digital Report 2024, o Brasil é o segundo país do mundo onde os usuários passam maior tempo online.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Existem 245 milhões de usuários no X, com mais de 500 milhões de postagens por dia, sendo o Brasil a quarta maior base de usuários desta plataforma no mundo.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
<sec>
<title>Uso atual do X na imagem cardiovascular</title>
<p>Na área de imagem cardiovascular, apesar do frequente enfoque em multimodalidade nas publicações, que refletem muito a nossa prática clínica, no X há uma subdivisão de conteúdo entre as principais modalidades diagnósticas, identificadas pelas abreviaturas após o símbolo &quot;#&quot; (&quot;hashtag&quot;): 1- #EchoFirst : ecocardiografia, 2- #YesCCT : tomografia computadorizada cardíaca, 3- #WhyCMR : ressonância magnética cardíaca e 4- #CVNuc cardiologia nuclear (<xref ref-type="table" rid="t4">Tabela 1</xref>). O uso dessas &quot;hashtags&quot; permite uma busca direcionada por campo de pesquisa dentro da própria plataforma, facilitando a triagem de conteúdo relacionado a cada uma destas áreas específicas. Utilizando a ferramenta de busca, podemos também selecionar postagens especificamente por patologias, usando a # seguida do termo (exemplo: #Ebstein), ou buscar pelo nome alguns médicos de renome em determinadas áreas de expertise. É possível monitorizar o tráfego das publicações marcadas com # (metadata tags), com o uso de programas específicos ou sites para esse fim (<ext-link ext-link-type="uri" xlink:href="https://www.symplur.com">https://www.symplur.com</ext-link>, por exemplo). Durante congressos, normalmente são criadas &quot;hashtags&quot; específicas, para marcar conteúdo publicado em correlação às atividades e programação desses eventos, que podem ser utilizadas por congressistas em geral ou por times focados nesta divulgação, os chamados times de mídias sociais (SoMe), ou mesmo &quot;embaixadores&quot; de mídias sociais (&quot;#SoMe ambassadors&quot;). Como exemplo, durante o congresso da Sociedade Americana de Ecocardiografia em junho de 2024, utilizando nas postagens o marcador #ASE2024, podemos observar que no período de 11/06 a 16/06 de 2024 tivemos 2019 posts relacionados, com incríveis 24.292.000 impressões (<xref ref-type="fig" rid="f4">Figura 1</xref>), dados que permitem dimensionar o alcance e penetração do evento nessa plataforma, como um &quot;termômetro&quot; que auxilia na avaliação do desempenho de atividades específicas, repercussão do evento em geral e planejamento de ações futuras.</p>
<table-wrap id="t4">
<label>Tabela 1</label>
<caption>
<title>Principais hashtags (#) relacionadas a imagem cardiovascular identificadas no X</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="50%">
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#C58874">
<th align="left" valign="middle">Sigla</th>
<th align="center" valign="middle">Significado</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr>
<td align="left" valign="middle">#EchoFirst</td>
<td align="center" valign="middle">Echocardiography</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#YesCCT</td>
<td align="center" valign="middle">Cardiac computed tomography</td>
</tr>
<tr>
<td align="left" valign="middle">#WhyCMR</td>
<td align="center" valign="middle">Cardiac magnetic resonance</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#CVNuc</td>
<td align="center" valign="middle">Nuclear cardiology</td>
</tr>
<tr>
<td align="left" valign="middle">#TreatTR</td>
<td align="center" valign="middle">Interventional treatment of tricuspid regurgitation</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#3DEcho</td>
<td align="center" valign="middle">3D echocardiography</td>
</tr>
<tr>
<td align="left" valign="middle">#IC</td>
<td align="center" valign="middle">Interventional Cardiology</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#CardioTwitter</td>
<td align="center" valign="middle">Cardiology community</td>
</tr>
<tr>
<td align="left" valign="middle">#CardioED</td>
<td align="center" valign="middle">Education in cardiology</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#CVImaging</td>
<td align="center" valign="middle">Cardiovascular Imaging</td>
</tr>
<tr>
<td align="left" valign="middle">#VHD</td>
<td align="center" valign="middle">Valvular heart disease</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">#ACHD</td>
<td align="center" valign="middle">Adult congenital heart disease</td>
</tr>
<tr>
<td align="left" valign="middle">#HF</td>
<td align="center" valign="middle">Heart failure</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f4">
<label>Figura 1</label>
<caption>
<title>Avaliação de impressões de postagens relacionadas ao hashtag #ASE2024 durante o congresso da Sociedade Americana de Ecocardiografia de 2024, demonstrando alcance e impacto das publicações e dos influenciadores digitais durante o período de 11-16 de junho. Dados extraídos da plataforma Symplur (TM).</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240109-gf01-pt.tif"/>
</fig>
<p>Na prática clínica, muitas vezes nos deparamos com doenças raras e desafiadoras, nas quais a experiência pode ser decisiva para um rápido diagnóstico, sendo a discussão entre pares, fundamental para essa tarefa. Doenças com distribuição regional podem ser raras em alguns países e endêmicas em outras partes do mundo, como, por exemplo, a cardiopatia reumática, que é endêmica na América do Sul e América Central. Imagens ecocardiográficas podem ser divulgadas rapidamente, por exemplo, e facilitar que um médico com grande expertise neste assunto ajude a um outro que nunca viu a doença a realizar o diagnóstico correto e orientar possíveis opções terapêuticas, simulando um &quot;Heart Team&quot; virtual e em tempo real.</p>
<p>Com o uso do X, podemos também difundir o melhor uso de novas técnicas e ferramentas na imagem cardiovascular, como, por exemplo, na forma de tutoriais (&quot;tweetorials&quot;)<sup><xref ref-type="bibr" rid="B3">3</xref></sup> ou ilustrando seu uso no contexto de doenças específicas e casos comentados. Pela limitação de caracteres, muitos tutoriais se destinam a desenvolver um assunto de forma sequencial, com postagens encadeadas sobre determinado tema, denominadas &quot;fios&quot; ou &quot;threads&quot;, que podem ser ilustradas com figuras ou vídeos, trazendo informação mais consistente sobre determinado assunto. A esse conteúdo, podemos também adicionar enquetes interativas sobre o assunto, denominados &quot;polls&quot;, que potencializam o engajamento e geram dados anônimos que ajudam a identificar padrões e tendências, e podem até mesmo ser utilizadas em publicações científicas, exposições em conferências ou em posts correlacionados.</p>
</sec>
<sec>
<title>Em resumo, abaixo estão relacionados os principais usos da plataforma X na imagem cardiovascular:</title>
<list list-type="roman-upper">
<list-item><p>Divulgação de técnicas ou abordagens diagnósticas específicas, por meio de discussões ou vídeos ilustrativos. Como exemplo, a descrição de novas janelas ecocardiográficas (<ext-link ext-link-type="uri" xlink:href="https://x.com/alexsfelixecho/status/1813967278964101463">https://x.com/alexsfelixecho/status/1813967278964101463</ext-link>) ou a popularização de outras janelas pouco utilizadas, como a paraesternal direita (<ext-link ext-link-type="uri" xlink:href="https://x.com/nat_echo/status/1508827908101529601">https://x.com/nat_echo/status/1508827908101529601</ext-link>). Médicos mais jovens em treinamento, tal como residentes ou &quot;fellows&quot;, em particular, recorrem às mídias sociais para buscar dicas e tirar dúvidas com médicos mais experientes;</p></list-item>
<list-item><p>Uso para recrutamento de centros de pesquisa ou mesmo inclusão de pacientes em trabalhos científicos randomizados;</p></list-item>
<list-item><p>Clubes de revista e outras formas de interação entre profissionais pelo X para fins acadêmicos e científicos. Encontram-se discussões de temas importantes, ou publicações recentes, com análise de seu impacto na prática clínica, muitas vezes patrocinadas por grandes jornais da área de imagem cardiovascular ou iniciativas de sociedades, como, por exemplo, o ASE Journal Club da sociedade americana de ecocardiografia. Todas essas atividades têm hashtags específicas que marcam as discussões;</p></list-item>
<list-item><p>Discussão de casos complexos, incluindo imagens e vídeos de casos desafiadores, que suscitam opiniões de experts no assunto, e discussão de possíveis complementações diagnósticas e abordagem terapêutica;</p></list-item>
<list-item><p>Tutoriais, também denominados &quot;tweetorials&quot;, postagens sequenciais sobre algum assunto que podem abranger tópicos diversos desde conceitos básicos, dados estatísticos de publicações relacionadas e referências a novas pesquisas e inovações, com a intenção de uma revisão abreviada de determinado tema ou discussão sobre algum artigo ou trial específico;</p></list-item>
<list-item><p>Publicações voltadas para pacientes e população leiga, com conteúdo focado em gerar conhecimento sobre determinadas doenças (&quot;awareness&quot;), seu diagnóstico e possibilidade de tratamento;<sup><xref ref-type="bibr" rid="B4">4</xref></sup></p></list-item>
<list-item><p>Uso para possibilitar que a comunidade acompanhe as últimas notícias de trials ou publicações, divulgadas em grandes conferências, em tempo real, com a possibilidade de discussão e enfoque em pontos importantes sobre novas diretrizes e o impacto sobre a nossa prática clínica;</p></list-item>
<list-item><p>Estímulo à inclusão ou visibilidade a grupo específico, como, por exemplo, à maior inclusão feminina na cardiologia, como o movimento #WIC (&quot;women in cardiology&quot;),<sup><xref ref-type="bibr" rid="B5">5</xref></sup> reduzindo a diferença em representação e participação acadêmica e científica;</p></list-item>
<list-item><p>Fórum para discussões críticas de artigos, abertas de forma democrática para o debate público entre profissionais da área.</p></list-item>
</list>
<p>Quando utilizado devidamente, o X abre portas de conhecimento e constitui fonte importante de atualização e de discussão de casos. Algumas contas são particularmente ativas e úteis, postando conteúdo relevante e suscitando discussões importantes para a educação na área de imagem cardiovascular. Seria impossível incluir as contas de todos os influenciadores digitais com relevância na área de imagem cardiovascular do X nesta publicação, mas na <xref ref-type="table" rid="t5">Tabela 2</xref> são sugeridas 51 contas para seguir, que podem servir como um bom início para novos usuários do X.</p>
<table-wrap id="t5">
<label>Tabela 2</label>
<caption>
<title>Alguns perfis de profissionais relacionados a imagem cardiovascular recomendados pelo autor.</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="33%">
<col/>
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#C58874">
<th align="left" valign="middle">Perfil (@)</th>
<th align="center" valign="middle">Profissional</th>
<th align="center" valign="middle">País</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@alcantaramonica</td>
<td align="center" valign="middle">Monica Alcantara</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@alex1708ander</td>
<td align="center" valign="middle">Alexander Mladenow</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@alexsfelixecho</td>
<td align="center" valign="middle">Alex Felix</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@AntonioBarros_</td>
<td align="center" valign="middle">Antonio Carlos L. de Barros Filho</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@argulian</td>
<td align="center" valign="middle">Edgar Argulian</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@cardiopedhnn</td>
<td align="center" valign="middle">Jorge Faerron</td>
<td align="center" valign="middle">COSTA RICA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@CASivaram1</td>
<td align="center" valign="middle">Chittur Sivaram</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@ctinocomesquita</td>
<td align="center" valign="middle">Claudio Tinoco Mesquita</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@denisamuraru</td>
<td align="center" valign="middle">Denisa Muraru</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr>
<td align="left" valign="middle">@DonalErwan</td>
<td align="center" valign="middle">Erwan Donal</td>
<td align="center" valign="middle">FRANCE</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@dr_benoy_n_shah</td>
<td align="center" valign="middle">Benoy Shah</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr>
<td align="left" valign="middle">@drahmedmohsen85</td>
<td align="center" valign="middle">Ahmed Mohsen</td>
<td align="center" valign="middle">EGYPT</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@drEdgarFuentes</td>
<td align="center" valign="middle">Edgar Fuentes Molina</td>
<td align="center" valign="middle">COSTA RICA</td>
</tr>
<tr>
<td align="left" valign="middle">@drozgeozden</td>
<td align="center" valign="middle">Ozge Ozden Kayhan</td>
<td align="center" valign="middle">TURKEY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@DrRajeshG1</td>
<td align="center" valign="middle">Gopalan Nair Rajesh</td>
<td align="center" valign="middle">INDIA</td>
</tr>
<tr>
<td align="left" valign="middle">@echo_stepbystep</td>
<td align="center" valign="middle">Vladyslav Kavalerchyk</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@EchoSoliman</td>
<td align="center" valign="middle">Hatem Soliman</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr>
<td align="left" valign="middle">@echotalk</td>
<td align="center" valign="middle">Jose Roberto R. Matos-Souza</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@ecocardio_cl</td>
<td align="center" valign="middle">Julián Vega Auday</td>
<td align="center" valign="middle">CHILE</td>
</tr>
<tr>
<td align="left" valign="middle">@EGarciaSayan</td>
<td align="center" valign="middle">Enrique Garcia-Sayan</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@FGraziani_Grace</td>
<td align="center" valign="middle">Francesca Graziani</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr>
<td align="left" valign="middle">@fiore_corrado</td>
<td align="center" valign="middle">Corrado Fiore</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@GE_IanMc</td>
<td align="center" valign="middle">Ian McLeod</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr>
<td align="left" valign="middle">@GoncalvesCortez</td>
<td align="center" valign="middle">Arthur Cortez</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@HeartToProve</td>
<td align="center" valign="middle">Carlos El-Tallawi</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@iamritu</td>
<td align="center" valign="middle">Ritu Thamman</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@Irina67790690</td>
<td align="center" valign="middle">Irina Akhmedova</td>
<td align="center" valign="middle">KYRGYZSTAN</td>
</tr>
<tr>
<td align="left" valign="middle">@KemalogluOz</td>
<td align="center" valign="middle">Tugba Kemaloglu Oz</td>
<td align="center" valign="middle">AUSTRALIA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@kevin_domingues</td>
<td align="center" valign="middle">Kevin Domingues</td>
<td align="center" valign="middle">PORTUGAL</td>
</tr>
<tr>
<td align="left" valign="middle">@LopezOpitz</td>
<td align="center" valign="middle">J. Lopez-Opitz</td>
<td align="center" valign="middle">CHILE</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@lpbadano</td>
<td align="center" valign="middle">Luigi P. Badano</td>
<td align="center" valign="middle">ITALY</td>
</tr>
<tr>
<td align="left" valign="middle">@MAecocardio</td>
<td align="center" valign="middle">Miguel A. Garcia Fernandez</td>
<td align="center" valign="middle">SPAIN</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@marcelohaertel</td>
<td align="center" valign="middle">Marcelo Haertel Miglioranza</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@marciomp50</td>
<td align="center" valign="middle">Marcio Mendes</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@NadeenFaza</td>
<td align="center" valign="middle">Nadeen N. Faza</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@NMerke</td>
<td align="center" valign="middle">Nicolas Merke</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@ono_cardiology</td>
<td align="center" valign="middle">Juan Lopez-Mattei</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@OungSavly</td>
<td align="center" valign="middle">Oung Savly</td>
<td align="center" valign="middle">CAMBODIA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@papadocardio</td>
<td align="center" valign="middle">Konstantinos Papadopoulos</td>
<td align="center" valign="middle">GREECE</td>
</tr>
<tr>
<td align="left" valign="middle">@pattypellikka</td>
<td align="center" valign="middle">Patricia Pellikka</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@purviparwani</td>
<td align="center" valign="middle">Purvi Parwani</td>
<td align="center" valign="middle">USA</td>
</tr>
<tr>
<td align="left" valign="middle">@RodrigogpLima</td>
<td align="center" valign="middle">Rodrigo G. P. Lima</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@RODRIGOVISCONT1</td>
<td align="center" valign="middle">Rodrigo Visconti</td>
<td align="center" valign="middle">BRAZIL</td>
</tr>
<tr>
<td align="left" valign="middle">@Sarah_Moharem</td>
<td align="center" valign="middle">Sarah Moharem Elgamal</td>
<td align="center" valign="middle">ENGLAND</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@senguptasp</td>
<td align="center" valign="middle">Shantanu Sengupta</td>
<td align="center" valign="middle">INDIA</td>
</tr>
<tr>
<td align="left" valign="middle">@StellEkaterina</td>
<td align="center" valign="middle">Ekaterina Stellbrink</td>
<td align="center" valign="middle">GERMANY</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@strain_rate</td>
<td align="center" valign="middle">Asbjørn Støylen</td>
<td align="center" valign="middle">NORWAY</td>
</tr>
<tr>
<td align="left" valign="middle">@VazyurVasquez</td>
<td align="center" valign="middle">Zuilma Vásquez</td>
<td align="center" valign="middle">MEXICO</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@VDelgadoGarcia</td>
<td align="center" valign="middle">Victoria Delgado</td>
<td align="center" valign="middle">SPAIN</td>
</tr>
<tr>
<td align="left" valign="middle">@VerwerftJan</td>
<td align="center" valign="middle">Jan Verwerft</td>
<td align="center" valign="middle">BELGIUM</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">@VLSorrelImages</td>
<td align="center" valign="middle">V. L. Sorrell</td>
<td align="center" valign="middle">USA</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Riscos das mídias sociais para o uso em medicina</title>
<p>Como qualquer mídia social, apesar dos grandes avanços e funcionalidades apresentadas, temos que observar questões éticas e de boa conduta nas postagens realizadas no X, reforçando nosso foco de cuidado principal em nossos pacientes. As plataformas são públicas, e devemos lembrar que os pacientes e seus familiares têm acesso às postagens, e devem ser protegidos em sua privacidade (<xref ref-type="table" rid="t6">Tabela 3</xref>).</p>
<table-wrap id="t6">
<label>Tabela 3</label>
<caption>
<title>Sugestões sobre como realizar postagens relevantes no X, evitando riscos e exposição de pacientes e instituições.</title></caption>
<table frame="hsides" rules="groups">
<colgroup width="33%">
<col/>
<col/>
<col/>
</colgroup>
<thead style="border-top: thin solid; border-bottom: thin solid; border-color: #000000">
<tr style="background-color:#C58874">
<th align="left" valign="middle">Recomendado</th>
<th align="center" valign="middle">Cautela</th>
<th align="center" valign="middle">Não fazer</th>
</tr>
</thead>
<tbody style="border-bottom: thin solid; border-color: #000000">
<tr>
<td align="left" valign="middle">Siga as políticas de sua instituição e de seu país.</td>
<td align="center" valign="middle">Ao abordar temas sensíveis (religião, política).</td>
<td align="center" valign="middle">Nunca exponha dados dos pacientes.</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">Busque um nicho específico/área de interesse.</td>
<td align="center" valign="middle">Sempre avaliar como um meme ou figura podem ser interpretados.</td>
<td align="center" valign="middle">Nunca exponha fotos de pacientes.</td>
</tr>
<tr>
<td align="left" valign="middle">Tente postar de acordo com as melhores práticas/uso de bom senso.</td>
<td align="center" valign="middle">Ao postar casos clínicos e imagens, cuidado em despersonalizar e não expor pacientes.</td>
<td align="center" valign="middle">Não exponha dados da instituição, datas ou algo que possa levar indiretamente à identificação do paciente.</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">Tente responder às perguntas técnicas sobre sua postagem.</td>
<td align="center" valign="middle">Avalie separar perfis profissionais de pessoais.</td>
<td align="center" valign="middle">Não dê conselhos médicos específicos que possam ser encarados como definições diagnósticas ou tratamentos.</td>
</tr>
<tr>
<td align="left" valign="middle">Dê sempre o crédito quando retuitar algo.</td>
<td align="center" valign="middle">Deixar sempre claro no caso de qualquer conflito de interesses com a postagem.</td>
<td align="center" valign="middle">Não discuta questões médicas diretamente com pacientes no X.</td>
</tr>
<tr style="background-color:#E8CCBF">
<td align="left" valign="middle">Seja profissional e gentil nas postagens.</td>
<td align="center" valign="middle">Tente controlar o tempo de uso em mídias sociais.</td>
<td align="left" valign="middle"/>
</tr>
<tr>
<td align="left" valign="middle">Siga formadores de opinião em sua área.</td>
<td align="left" valign="middle"/>
<td align="left" valign="middle"/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec>
<title>Há alguns riscos e cuidados necessários no uso de mídias sociais para a postagem de conteúdo médico:</title>
<list list-type="roman-upper">
<list-item><p>A privacidade dos pacientes é a questão principal, não devemos nunca expor os seus dados ou qualquer forma de identificação;</p></list-item>
<list-item><p>Jamais devemos expor outros profissionais ou instituições por meio de postagens contendo opiniões pessoais, ou que exponham dados de tratamentos ou pacientes admitidos nestas instituições;</p></list-item>
<list-item><p>A limitação do número de caracteres ou mesmo o formato de divulgação das postagens podem levar a uma comunicação inadequada, levando a interpretações errôneas. A comunicação escrita, por si só, pode muitas vezes ser inadequada, pela falta de tom ou contexto, podendo levar a conclusões erradas em alguns casos;</p></list-item>
<list-item><p>A falta de revisão dos dados ou informações por pares, a chamada &quot;peer-review&quot;, pode permitir que informações sem bases científicas sejam apresentadas como corretas e definitivas;</p></list-item>
<list-item><p>Não há regulação sobre as atividades ou checagem se as pessoas são realmente médicas ou especialistas em alguma área, o que afeta a credibilidade das postagens.</p></list-item>
</list>
</sec>
<sec>
<title>Boas práticas no uso do X para a imagem cardiovascular</title>
<p>Baseado no que foi exposto acima, boas práticas para o uso de mídias sociais na área de imagem cardiovascular são necessárias, para que possamos manter o cuidado ético e profissional dos nossos pacientes<sup><xref ref-type="bibr" rid="B6">6</xref></sup> e seguir no objetivo de promover qualidade e aprendizado, com o uso dessa importante ferramenta de comunicação e divulgação de informações.</p>
<p>O acrônimo RESPECT resume muitas destas considerações (<xref ref-type="fig" rid="f5">Figura 2</xref>), pautando as postagens com (R)esponsabilidade, (E)vidências baseando as colocações, (S)ensibilidade e bom senso no conteúdo e forma com as quais montamos as postagens, preservando a (P)rivacidade dos pacientes, com finalidade (E)ducacional ou de pesquisa, obtendo o (C)onsentimento do paciente quando cabível, e sempre com o uso de informações (T)ecnicamente embasadas.</p>
<fig id="f5">
<label>Figura 2</label>
<caption>
<title>Acrônimo sobre normas de boa conduta para publicação de posts técnicos na área de imagem cardiovascular no X: RESPECT. Principais hashtags que identificam os principais métodos da imagem cardiovascular: #EchoFirst : ecocardiografia, #YesCCT : tomografia computadorizada cardíaca, #WhyCMR : ressonância magnética cardíaca e #CVNuc cardiologia nuclear</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240109-gf02-pt.tif"/>
</fig>
<p>Devem ser observadas também regras institucionais para a exposição de imagens e informações, além de sempre tornados transparentes quaisquer conflitos de interesse quando o profissional tiver relação com a indústria, jornais médicos, alguma sociedade ou com algum trial específico, quando as postagens forem relacionadas a estes.</p>
<p>Em relação às opiniões e comentários emitidos na plataforma, é sempre importante lembrar que a medicina requer o contato humano, a relação médico-paciente, o exame físico minucioso, e por isso a análise de imagens selecionadas, ou informações fragmentadas, e não inseridas em um &quot;todo&quot; que envolva todos esses fatores podem levar a erros de diagnóstico e conduta, e, dessa forma, precisam ser utilizados com bom senso e cautela. Muitos médicos colocam a frase em seu perfil: &quot;retweet ≠ endorsement&quot; (retuitar ≠ endosso), &quot;personal views ≠ medical advise&quot; (opiniões pessoais ≠ orientação médica), &quot;tweets = my opinion&quot; (tuítes = minha opinião), como uma forma de tornar evidente que comentários ali colocados refletem apenas suas opiniões pessoais e não podem servir como um definidor de conduta.</p>
</sec>
<sec>
<title>Uso acadêmico do X</title>
<p>O uso das redes sociais tem modificado a forma como a academia determina a influência no meio médico e seu poder sobre o conteúdo das informações. Atualmente, qualquer pessoa pode publicar livremente o que quiser em tempo real, sem qualquer restrição ou processo de &quot;peer-review&quot;, fazendo com que pertencer aos meios acadêmicos não seja mais um pré-requisito para influência e reconhecimento. Novas iniciativas têm surgido a partir das conexões digitais e &quot;networking&quot; que se estabelecem por meio das redes sociais, como a criação de grupos de discussão, comunidades digitais, ou mesmo o surgimento de iniciativas que reúnem pessoas que se conhecem apenas digitalmente e decidem organizar projetos em conjunto, tais como encontros virtuais ou presenciais, redação de artigos em colaboração, e redação de livros, dentre outros. Como exemplo, houve recentemente a criação de uma sociedade de cardiologia em ambiente totalmente digital e on-line em 2022, a GSOC (Global Society of Cardiology - conta X: @GSoCers), agregando membros de vários países colaborando de forma virtual. Por iniciativa desse grupo, foi realizado o primeiro Congresso de Cardiologia no Metaverso, que contou com a presença de renomados palestrantes em um ambiente totalmente virtual, com grande audiência (<xref ref-type="fig" rid="f6">Figura 3</xref>).</p>
<fig id="f6">
<label>Figura 3</label>
<caption>
<title>Exemplo de iniciativas científicas, educacionais e de networking proporcionadas pelas mídias sociais, juntando amigos virtuais de todas as partes do globo. Imagens de um congresso todo virtual realizado no Metaverso (promovido pela GSOC) com avatares representando palestrantes e público.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240109-gf03-pt.tif"/>
</fig>
<p>O X também pode ser utilizado como ferramenta de pesquisa, por meio de &quot;surveys&quot; (pesquisas) ou &quot;polls&quot; (enquetes), em que os dados podem ser coletados diretamente pela participação de usuários. Outra forma de fomentar pesquisas é pelo recrutamento direto de indivíduos elegíveis para a inclusão em registros, pelo chamamento direto pelas redes sociais que pode ter como alvo os próprios pacientes, outros profissionais ou instituições que porventura possam ter pacientes que se beneficiariam dessa participação.</p>
</sec>
<sec>
<title>Apesar de se tratar de uma rede social, algumas regras de boa conduta são importantes para a atuação no X:</title>
<list list-type="roman-upper">
<list-item><p>É importante citar as referências ou marcar especialistas, autores ou editores quando estiver discutindo algum artigo, ou quando postar alguma parte deste ou figura/tabela.</p></list-item>
<list-item><p>Sempre se deve dar a devida referência à autoria de postagem de outro usuário ao repostá-la ou ao realizar nova postagem pessoal utilizando tal postagem parcial ou integralmente, sendo ela texto, imagem ou vídeo.</p></list-item>
<list-item><p>É importante utilizar sempre um discurso profissional quando debater assunto científico, com tom respeitoso, sempre da forma mais técnica possível.</p></list-item>
<list-item><p>Deve-se sempre deixar bem claro na postagem quando o uso de uma técnica for &quot;off-label&quot;.</p></list-item>
</list>
<p>Estudos demonstram que artigos divulgados em redes sociais ganham maior visibilidade e número de acessos, citações e downloads,<sup><xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref></sup> impulsionando os usuários do X a buscarem conteúdo nas plataformas digitais desses jornais online.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> O X é ferramenta importante para o impulsionamento de relatos de casos ou pesquisas científicas,<sup><xref ref-type="bibr" rid="B10">10</xref></sup> e o acesso aos artigos de jornais provenientes de mídias sociais são monitorizados por métricas alternativas como o índice Altmetric (<ext-link ext-link-type="uri" xlink:href="https://www.altmetric.com">https://www.altmetric.com</ext-link>), que inclui referências a pesquisas além das publicações médicas, que incluem: citações na imprensa e sites, blogs online, Wikipedia e redes sociais, como o X. O índice Altmetric é ligado ao endereço URL do artigo, e consegue avaliar de forma mais ágil que índices convencionais (H-Index) o desempenho de um artigo no que se refere às impressões e alcance entre os leitores.</p>
</sec>
</sec>
<sec sec-type="conclusions">
<title>Conclusão</title>
<p>O uso das mídias sociais na área de imagem cardiovascular revolucionou a forma com que nos conectamos e dividimos conhecimento. O X tem características que o tornam uma plataforma atraente para discussões de casos clínicos, divulgação de novas tecnologias e pesquisas científicas em tempo real, de forma dinâmica e interativa. Devemos sempre buscar observar as regras de boa prática, nos pautando por limites éticos e protegendo sempre a privacidade dos pacientes, lembrando que o X é mais uma importante ferramenta para o benefício dos nossos pacientes, que são o foco do cuidado.</p>
</sec>
</body>
</sub-article>
</article>
